Back to All Events

2026 Best of ASCO® Los Angeles


  • Le Méridien Pasadena Arcadia 130 West Huntington Drive Arcadia, CA, 91007 United States (map)

In-Person Access Only | 8.25 CME Credits & MOC Points

Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Los Angeles Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Conference Agenda
Saturday, June 13, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome‍ ‍
Nataliya Mar, MD | Chao Comprehensive Cancer Center - University of California Irvine

8:40 AM
Colorectal Cancer
Nicholas Hornstein, MD | Northwell Health

9:10 AM
Head and Neck Cancer
Ezra Cohen, MD | University of San Diego

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Regeneron - Immunotherapy In Practice: A Compelling Case-Based Discussion Examining Actual Patients with NSCLC

Shiven Patel, MD | Huntsman Cancer Institute, University of Utah

10:40 AM
Prostate Cancer
Nataliya Mar, MD | Chao Comprehensive Cancer Center - University of California Irvine - Program Chair

11:10 AM
Non-Prostate Cancer

Bradley McGregor, MD | Dana Farber Cancer Institute‍ ‍

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Incyte - Redefining the Treatment of Squamos Cell Carcinoma of the Anal Canal (SCAC) | ZYNYZ® (retifanlimab-dlwr) The First and Only FDA-Approved PD-1 Inhibitor for Adults with Inoperable Locally Recurrent or Metastatic SCAC

Jennifer Valerin, MD | University of California at Irvine

12:40 PM
Housekeeping and Survey

12:50 PM
Leukemia

Ann Mohrbacher, MD | USC Keck School of Medicine

1:20 PM
Lymphoma
Swetha Thiruvengadam, MD | City of Hope

1:50 PM
Multiple Myeloma
Rebecca Silbermann, MD | Oregon Health & Science University

2:20 PM
Melanoma

Vincent Ma, MD | University of Wisconsin, School of Medicine and Public Health

2:50 PM
Gynecological Oncology
Ritu Salani, MD | UCLA Health

3:30 PM
NETWORKING RECEPTION

Sunday, June 14, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Zev Wainberg, MD | UCLA Health - Program Chair


8:40 AM
Small Cell Lung Cancer

J.Marie Suga, MD, MPH | Kaiser Permanente

9:10 AM
Non-Small Cell Lung Cancer
Shiven Patel, MD | University of Utah

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Pfizer Breast - Treatment Considerations for Patients with HR+/HER2- mBC
Linnea Chap, MD | Beverly Hills Cancer
Center

10:40 AM
Non-Colorectal Cancer
Zev Wainberg, MD | UCLA Health - Program Chair

11:10 AM
Sarcomas and Rare Cancers
Leo Mascarenhas, MD, MS | Cedars-Sinai Medical Center

11:40 AM
Neuroedocrine Tumors
Jaydira Del Rivero, MD | Bethesda, MD

12:00 PM
Lunch and Exhibits

12:15 PM
Non-CME Lunch - AbbVie - Diving Deep into 1L CLL with BCL2 Inhibitor-Based Fixed-Duration Regimens

Shawn Streeter, PharmD | AbbVie

1:00 PM
Survivorship
Neha Goyal, PhD | UCSF

1:30 PM
Early-Stage Breast Cancer
Norah Lynn Henry, MD | University of Michigan

2:00 PM
Metastatic Breast Cancer
Kamel Abou Hussein, MD | Cooper University

2:30 PM
Adjourn

Agenda Subject To Change. All times are PST.

 
 
Previous
Previous
June 13

2026 Best of ASCO® Austin

Next
Next
June 13

2026 Best of ASCO® Puerto Rico